LDOS:NYSELeidos Holdings, Inc. Analysis

Leidos (LDOS) is trading at $124.39, comfortably above its 20‑day SMA of 135.77 and well below the 200‑day SMA of 176.95, indicating a bearish medium‑term trend. The 14‑day RSI sits at 25, signaling oversold conditions, while the MACD line remains negative and its histogram is declining, reinforcing short‑term downside pressure. Volatility has spiked to nearly 33% over the past 30 days and the stock’s beta of 0.40 suggests limited correlation with broader market moves, which together heighten price swing risk. Despite these technical headwinds, the company reported a 4% year‑over‑year revenue increase to $4.4 billion and beat earnings expectations by 7.39%, delivering a net income of $335 million. Fundamental metrics remain attractive: a trailing PE of 11.4 versus an industry average of 38.8, a solid ROE of 30.6%, and a modest dividend yield of 1.37% supported by a low payout ratio of 15%. However, the DCF‑derived fair value of $91.34 implies the current price is substantially overvalued, leaving limited upside and a downside potential of roughly 50%.
Given the overvalued price, the primary risk stems from a potential correction toward the fair‑value level, amplified by the high 30‑day volatility and a recent max drawdown of 38%. The defensive nature of Leidos’ government contracts mitigates sector and regulatory risk, keeping those exposures at medium and low respectively, while geographic and currency risks remain low. The dividend appears sustainable with a payout ratio well under 20% and ample cash flow, supporting income‑focused investors. In the short term, the oversold technical signals suggest a cautious hold, whereas the medium term outlook favors a neutral stance as earnings momentum and cash generation persist. Over a longer horizon, the company’s strong ROE, stable cash flow, and low beta make it a compelling buy for patient investors seeking exposure to the defense and IT services sector.